Skip to main content
Top
Published in: Diabetologia 5/2018

Open Access 01-05-2018 | Article

Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans

Authors: Mandy Stadion, Kristin Schwerbel, Antonia Graja, Christian Baumeier, Maria Rödiger, Wenke Jonas, Christian Wolfrum, Harald Staiger, Andreas Fritsche, Hans-Ulrich Häring, Nora Klöting, Matthias Blüher, Pamela Fischer-Posovszky, Tim J. Schulz, Hans-Georg Joost, Heike Vogel, Annette Schürmann

Published in: Diabetologia | Issue 5/2018

Login to get access

Abstract

Aims/hypothesis

Obesity results from a constant and complex interplay between environmental stimuli and predisposing genes. Recently, we identified the IFN-activated gene Ifi202b as the most likely gene responsible for the obesity quantitative trait locus Nob3 (New Zealand Obese [NZO] obesity 3). The aim of this study was to evaluate the effects of Ifi202b on body weight and adipose tissue biology, and to clarify the functional role of its human orthologue IFI16.

Methods

The impact of Ifi202b and its human orthologue IFI16 on adipogenesis was investigated by modulating their respective expression in murine 3T3-L1 and human Simpson-Golabi-Behmel syndrome (SGBS) pre-adipocytes. Furthermore, transgenic mice overexpressing IFI202b were generated and characterised with respect to metabolic traits. In humans, expression levels of IFI16 in adipose tissue were correlated with several variables of adipocyte function.

Results

In mice, IFI202b overexpression caused obesity (Δ body weight at the age of 30 weeks: 10.2 ± 1.9 g vs wild-type mice) marked by hypertrophic fat mass expansion, increased expression of Zfp423 (encoding the transcription factor zinc finger protein [ZFP] 423) and white-selective genes (Tcf21, Tle3), and decreased expression of thermogenic genes (e.g. Cidea, Ucp1). Compared with their wild-type littermates, Ifi202b transgenic mice displayed lower body temperature, hepatosteatosis and systemic insulin resistance. Suppression of IFI202b/IFI16 in pre-adipocytes impaired adipocyte differentiation and triacylglycerol storage. Humans with high levels of IFI16 exhibited larger adipocytes, an enhanced inflammatory state and impaired insulin-stimulated glucose uptake in white adipose tissue.

Conclusions/interpretation

Our findings reveal novel functions of Ifi202b and IFI16, demonstrating their role as obesity genes. These genes promote white adipogenesis and fat storage, thereby facilitating the development of obesity-associated insulin resistance.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Duval C, Thissen U, Keshtkar S et al (2010) Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice. Diabetes 59:3181–3191CrossRefPubMedPubMedCentral Duval C, Thissen U, Keshtkar S et al (2010) Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice. Diabetes 59:3181–3191CrossRefPubMedPubMedCentral
3.
go back to reference Cusi K (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 10:306–315CrossRefPubMed Cusi K (2010) The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 10:306–315CrossRefPubMed
4.
go back to reference Unger RH, Clark GO, Scherer PE, Orci L (2010) Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801:209–214CrossRefPubMed Unger RH, Clark GO, Scherer PE, Orci L (2010) Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801:209–214CrossRefPubMed
5.
go back to reference Montanari T, Pošćić N, Colitti M (2017) Factors involved in white-to-brown adipose tissue conversion and in thermogenesis: a review. Obes Rev 18:495–513CrossRefPubMed Montanari T, Pošćić N, Colitti M (2017) Factors involved in white-to-brown adipose tissue conversion and in thermogenesis: a review. Obes Rev 18:495–513CrossRefPubMed
6.
go back to reference Saely CH, Geiger K, Drexel H (2011) Brown versus white adipose tissue: a mini-review. Gerontology 58:15–23CrossRef Saely CH, Geiger K, Drexel H (2011) Brown versus white adipose tissue: a mini-review. Gerontology 58:15–23CrossRef
7.
go back to reference Cypess AM, White AP, Vernochet C et al (2013) Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med 19:635–639CrossRefPubMedPubMedCentral Cypess AM, White AP, Vernochet C et al (2013) Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med 19:635–639CrossRefPubMedPubMedCentral
8.
go back to reference Lidell ME, Betz MJ, Enerbäck S (2014) Two types of brown adipose tissue in humans. Adipocyte 3:63–66CrossRefPubMed Lidell ME, Betz MJ, Enerbäck S (2014) Two types of brown adipose tissue in humans. Adipocyte 3:63–66CrossRefPubMed
9.
go back to reference Ma X, Lee P, Chisholm DJ, James DE (2015) Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol 6:1 Ma X, Lee P, Chisholm DJ, James DE (2015) Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol 6:1
11.
go back to reference Guo L, Li X, Tang Q-Q (2014) L05 transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP). J Biol Chem 290:755–761CrossRefPubMedPubMedCentral Guo L, Li X, Tang Q-Q (2014) L05 transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP). J Biol Chem 290:755–761CrossRefPubMedPubMedCentral
12.
go back to reference Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798–800CrossRefPubMed Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA (1994) Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798–800CrossRefPubMed
13.
go back to reference Vogel H, Nestler M, Rüschendorf F et al (2009) Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1. Physiol Genomics 38:226–232CrossRefPubMedPubMedCentral Vogel H, Nestler M, Rüschendorf F et al (2009) Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1. Physiol Genomics 38:226–232CrossRefPubMedPubMedCentral
14.
go back to reference Vogel H, Scherneck S, Kanzleiter T et al (2012) Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Hum Mol Genet 21:3845–3857CrossRefPubMed Vogel H, Scherneck S, Kanzleiter T et al (2012) Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. Hum Mol Genet 21:3845–3857CrossRefPubMed
15.
16.
go back to reference Asefa B, Klarmann KD, Copeland NG et al (2003) The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 32:155–167CrossRef Asefa B, Klarmann KD, Copeland NG et al (2003) The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 32:155–167CrossRef
17.
go back to reference Choubey D, Duan X, Dickerson E et al (2010) Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interf Cytokine Res 30:371–380CrossRef Choubey D, Duan X, Dickerson E et al (2010) Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interf Cytokine Res 30:371–380CrossRef
18.
go back to reference Vogel H, Jähnert M, Stadion M et al (2017) A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance. BMC Genomics 18:172 Vogel H, Jähnert M, Stadion M et al (2017) A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance. BMC Genomics 18:172
19.
go back to reference Klein J, Fasshauer M, Ito M et al (1999) Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274:34795–34802CrossRefPubMed Klein J, Fasshauer M, Ito M et al (1999) Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274:34795–34802CrossRefPubMed
20.
go back to reference Tseng Y-H, Kriauciunas KM, Kokkotou E, Kahn CR (2004) Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24:1918–1929CrossRefPubMedPubMedCentral Tseng Y-H, Kriauciunas KM, Kokkotou E, Kahn CR (2004) Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24:1918–1929CrossRefPubMedPubMedCentral
21.
go back to reference Schulz TJ, Huang TL, Tran TT et al (2011) Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A 108:143–148CrossRefPubMed Schulz TJ, Huang TL, Tran TT et al (2011) Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl Acad Sci U S A 108:143–148CrossRefPubMed
22.
go back to reference Spangrude GJ, Klein J, Heimfeld S et al (1989) Two monoclonal antibodies identify thymic-repopulating cells in mouse bone marrow. J Immunol 142:425–430PubMed Spangrude GJ, Klein J, Heimfeld S et al (1989) Two monoclonal antibodies identify thymic-repopulating cells in mouse bone marrow. J Immunol 142:425–430PubMed
23.
go back to reference Rodeheffer MS, Birsoy K, Friedman JM (2008) Identification of white adipocyte progenitor cells in vivo. Cell 135:240–249CrossRefPubMed Rodeheffer MS, Birsoy K, Friedman JM (2008) Identification of white adipocyte progenitor cells in vivo. Cell 135:240–249CrossRefPubMed
24.
go back to reference Schulz N, Himmelbauer H, Rath M et al (2011) Role of medium- and short-chain L-3-hydroxyacyl- CoA dehydrogenase in the regulation of body weight and thermogenesis. Endocrinology 152:4641–4651CrossRefPubMedPubMedCentral Schulz N, Himmelbauer H, Rath M et al (2011) Role of medium- and short-chain L-3-hydroxyacyl- CoA dehydrogenase in the regulation of body weight and thermogenesis. Endocrinology 152:4641–4651CrossRefPubMedPubMedCentral
25.
go back to reference Kannt A, Pfenninger A, Teichert L et al (2015) Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58:799–808CrossRefPubMedPubMedCentral Kannt A, Pfenninger A, Teichert L et al (2015) Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58:799–808CrossRefPubMedPubMedCentral
26.
go back to reference Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506–E515CrossRefPubMed Klöting N, Fasshauer M, Dietrich A et al (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299:E506–E515CrossRefPubMed
27.
go back to reference Staiger H, Böhm A, Scheler M et al (2013) Common genetic variation in the human fndc5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 8:e61903CrossRefPubMedPubMedCentral Staiger H, Böhm A, Scheler M et al (2013) Common genetic variation in the human fndc5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 8:e61903CrossRefPubMedPubMedCentral
28.
go back to reference Finucane FM, Luan J, Wareham NJ et al (2009) Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345–2349CrossRefPubMedPubMedCentral Finucane FM, Luan J, Wareham NJ et al (2009) Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345–2349CrossRefPubMedPubMedCentral
31.
go back to reference Shao M, Ishibashi J, Kusminski CM et al (2016) Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program. Cell Metab 23:1167–1184CrossRefPubMedPubMedCentral Shao M, Ishibashi J, Kusminski CM et al (2016) Zfp423 maintains white adipocyte identity through suppression of the beige cell thermogenic gene program. Cell Metab 23:1167–1184CrossRefPubMedPubMedCentral
32.
go back to reference Gupta RK, Mepani RJ, Kleiner S et al (2012) Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 15:230–239CrossRefPubMedPubMedCentral Gupta RK, Mepani RJ, Kleiner S et al (2012) Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 15:230–239CrossRefPubMedPubMedCentral
33.
go back to reference Patil M, Sharma BK, Elattar S et al (2017) Id1 promotes obesity by suppressing brown adipose thermogenesis and white adipose browning. Diabetes 66:1611–1625CrossRefPubMed Patil M, Sharma BK, Elattar S et al (2017) Id1 promotes obesity by suppressing brown adipose thermogenesis and white adipose browning. Diabetes 66:1611–1625CrossRefPubMed
34.
go back to reference Stine RR, Shapira SN, Lim H-W et al (2016) EBF2 promotes the recruitment of beige adipocytes in white adipose tissue. Mol Metab 5:57–65CrossRefPubMed Stine RR, Shapira SN, Lim H-W et al (2016) EBF2 promotes the recruitment of beige adipocytes in white adipose tissue. Mol Metab 5:57–65CrossRefPubMed
35.
go back to reference Seale P, Conroe HM, Estall J et al (2011) Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121:96–105CrossRefPubMed Seale P, Conroe HM, Estall J et al (2011) Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 121:96–105CrossRefPubMed
36.
go back to reference Michailidou Z, Jensen MD, Dumesic DA et al (2007) Omental 11β-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity 15:1155–1163CrossRefPubMed Michailidou Z, Jensen MD, Dumesic DA et al (2007) Omental 11β-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity 15:1155–1163CrossRefPubMed
37.
go back to reference Shepherd PR, Gnudi L, Tozzo E et al (1993) Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed Shepherd PR, Gnudi L, Tozzo E et al (1993) Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268:22243–22246PubMed
38.
go back to reference Martinez-Botas J, Anderson JB, Tessier D et al (2000) Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26:474–479CrossRefPubMed Martinez-Botas J, Anderson JB, Tessier D et al (2000) Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26:474–479CrossRefPubMed
39.
go back to reference Tansey JT, Sztalryd C, Gruia-Gray J et al (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494–6499CrossRefPubMedPubMedCentral Tansey JT, Sztalryd C, Gruia-Gray J et al (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494–6499CrossRefPubMedPubMedCentral
41.
go back to reference van de Woestijne AP, Monajemi H, Kalkhoven E, Visseren FLJ (2011) Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev 12:829–840CrossRefPubMed van de Woestijne AP, Monajemi H, Kalkhoven E, Visseren FLJ (2011) Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev 12:829–840CrossRefPubMed
42.
Metadata
Title
Increased Ifi202b/IFI16 expression stimulates adipogenesis in mice and humans
Authors
Mandy Stadion
Kristin Schwerbel
Antonia Graja
Christian Baumeier
Maria Rödiger
Wenke Jonas
Christian Wolfrum
Harald Staiger
Andreas Fritsche
Hans-Ulrich Häring
Nora Klöting
Matthias Blüher
Pamela Fischer-Posovszky
Tim J. Schulz
Hans-Georg Joost
Heike Vogel
Annette Schürmann
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 5/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4571-9

Other articles of this Issue 5/2018

Diabetologia 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.